Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

The Best and Worst Investments of 2013

By Ben Steverman - 2013-12-06T18:41:13Z

Photograph by Rafe Swan/Getty Images 

Company Symbol % Change
6 of 22

Best Equity Mutual Fund

Fidelity Select Biotechnology Portfolio


FBIOX has stakes in 133 biotech companies. Its largest holding is Gilead Sciences (GILD), which doubled in the first 11 months of the year as it reported successful trials of new drugs and increased sales. One force driving biotech stocks, according to Bloomberg Industries, is acquisition activity by pharmaceutical companies eager for new drug pipelines. Analysts estimate mature U.S. biotech companies will boost sales 18 percent and earnings 25 percent in 2014. 

Of 1,392 U.S.-based equity mutual funds with assets of $500 million or more. Excluded are closed-end funds and those that rely on leverage.